SURGE Therapeutics
SURGE Therapeutics


Cambridge, MA, USA


Biotechnology · DeepTech · Health


1 - 10 employees


Series B

founded in


SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed. The company provides an injectable biodegradable hydrogel that allows for the prolonged, localized release of most cancer immunotherapy on the website of surgical tumor resection by focusing the dose at the right place and right time.

Something looks off?
Open jobs at SURGE Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.